|
Market Closed -
Toronto S.E.
23:00:00 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.330 CAD | +4.34% |
|
+5.61% | -10.17% |
| 10-01 | HLS Therapeutics Inc. Announces Board and Committee Changes | CI |
| 09-24 | HLS Therapeutics Gets TSX Acceptance to Increase Normal Course Issuer Bid | MT |
| Market Cap | 94.24M 84.16M 77.75M 70.46M 132M 8.95B 134M 936M 370M 4.69B 354M 346M 14.78B | P/E 2026 * |
-15x | P/E 2027 * | -44.2x |
|---|---|---|---|---|---|
| Enterprise Value | 94.24M 84.16M 77.75M 70.46M 132M 8.95B 134M 936M 370M 4.69B 354M 346M 14.78B | EV / Sales 2026 * |
1.62x | EV / Sales 2027 * | 1.45x |
| Free-Float |
99.44% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| HLS | Delayed | |
OTC Markets
| HLTRF | Delayed | |
|
Deutsche Boerse AG
| 74D | Delayed |
Last Transcript: HLS Therapeutics Inc.
| 1 day | +4.34% | ||
| 1 week | +5.61% | ||
| Current month | +3.10% | ||
| 1 month | +9.62% | ||
| 3 months | +5.35% | ||
| 6 months | -6.88% | ||
| Current year | -10.17% |
| 1 week | 4.08 |  | 4.34 |
| 1 month | 3.75 | | 4.43 |
| Current year | 3.56 | | 5.25 |
| 1 year | 3.56 | | 5.62 |
| 3 years | 3 | | 5.76 |
| 5 years | 3 | | 19.9 |
| 10 years | 3 | | 25.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Millian
CEO | Chief Executive Officer | 58 | 01/05/2023 |
John Hanna
DFI | Director of Finance/CFO | 61 | 26/01/2024 |
Jason Gross
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/06/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Rodney Hill
BRD | Director/Board Member | 58 | 12/03/2018 |
John Welborn
CHM | Chairman | 48 | 22/06/2023 |
Norma Beauchamp
BRD | Director/Board Member | 65 | 01/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 A | Tax | Company | 1,000 | 0.0032% | - | |
| 9/30/26 A | Tax | Company | -1,000 | 0.0032% | - | |
| 9/29/26 A | Tax | Company | 2,000 | 0.0065% | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.34% | +5.61% | -22.82% | -10.54% | 94.24M | |
| -2.54% | +1.31% | +55.10% | +120.84% | 1,135B | |
| -1.42% | +3.23% | +37.07% | +74.26% | 636B | |
| +0.16% | +0.08% | +25.14% | +97.36% | 505B | |
| -0.31% | +3.09% | +43.92% | +64.55% | 378B | |
| -1.34% | -0.47% | +66.63% | +40.56% | 358B | |
| -0.68% | +2.65% | +22.46% | +51.48% | 295B | |
| -1.20% | +3.04% | +2.62% | +26.97% | 266B | |
| -1.79% | +1.57% | +49.97% | +60.87% | 237B | |
| -0.73% | -0.10% | +29.24% | +101.19% | 193B | |
| Average | -0.17% | +2.51% | +30.94% | +62.75% | 400.44B | |
| Weighted average by Cap. | -0.26% | +2.66% | +40.99% | +82.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.34M 52.1M 48.13M 43.61M 81.6M 5.54B 82.95M 579M 229M 2.9B 219M 214M 9.15B | 65.06M 58.1M 53.67M 48.64M 90.99M 6.18B 92.5M 646M 256M 3.24B 244M 239M 10.2B |
| Net income | -5.47M -4.88M -4.51M -4.09M -7.65M -519M -7.78M -54.3M -21.5M -272M -20.53M -20.09M -858M | -2.16M -1.93M -1.79M -1.62M -3.03M -205M -3.08M -21.49M -8.51M -108M -8.12M -7.95M -339M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | CA$4.330 | +4.34% | 125,900 |
| 22/10/26 | CA$4.150 | +0.48% | 7,100 |
| 21/10/26 | CA$4.130 | -0.48% | 13,102 |
| 20/10/26 | CA$4.150 | +1.47% | 23,771 |
| 19/10/26 | CA$4.090 | -0.24% | 4,649 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HLS Stock
Select your edition
All financial news and data tailored to specific country editions
